AGER and postmenopausal osteoporosis: Since oxidative stress promotes AGE formation, inhibiting normal enzymatically derived crosslinking and degrading the collagen structure with an increase in fracture risk, antioxidant therapies have been proposed to interfere with this positive feedback loop mediated by RAGE signaling in postmenopausal osteoporosis [44].